Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymosin Beta 4 for Severe Dry Eye
NCT01393132Phase 2Completed
- Sponsor
- Michigan Cornea Consultants
- Start
- Mar 2011
- Primary completion
- Dec 2012
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in dry eye syndrome (DED) comparing Thymosin Beta 4 with Vehicle Control (2 arms). Primary endpoint: Safety at Day 56. Started Mar 2011; status: completed.
02
Drugs
thymosin beta-4
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT01393132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393132.